| (EUR) | Sep 2024 | Y/Y change |
|---|---|---|
| Revenue | 18.02B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GU5.F returned +36.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +11.3% |
| 1 year | +36.6% |
| 5 years | +548.4% |
| 10 years | +1938.2% |
| All-time high | €4.44 (Apr 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in GU5.F would be worth today ›Yes. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited paid 2 dividends over the past 12 months. The most recent was €0.06 per share on Jun 12, 2026. The dividend yield is 6.56%.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is part of the Healthcare sector.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has a market cap of 2.44B EUR, based on the latest quote.
